Gregory Grant
Foot & Ankle Surgery · Seattle, WANPI 1154324812
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $4,101 of the $5,751 with a category attached, or 71.3%. 8 manufacturers reported payments, led by Paragon 28, Inc. at 41.3% of the total. Reporting peaked in 2023 at $1,912 and has fallen 67.2% since, to $627 in 2025.
Across 32 payments — averaging $179.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$2K
- Treace Medical Concepts, Inc.$1K
- Summit Surgical Corp.$808
- Arthrex$597
- Alaska Medical Technologies, LLC$557
- Bone Support Inc.$178
- plus $32 from 2 others
What the payments were for
- Travel & lodging$4,10171%
- Food & beverage$1,65029%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 10 | $2,374 |
| Treace Medical Concepts, Inc. | 9 | $1,204 |
| Summit Surgical Corp. | 4 | $808 |
| Arthrex | 5 | $597 |
| Alaska Medical Technologies, LLC | 1 | $557 |
| Bone Support Inc. | 1 | $178 |
| Bioventus LLC | 1 | $20 |
| Zimmer Biomet | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$916
- APEX 3D$865
- Portfolio$333
- CERAMENTBONE VOID FILLER$178
How this compares
$5,751 in reported general payments places this provider in the 75th percentile of 203 foot & ankle surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 34 | $5,780 |
| Ondansetron Hcl | 18 | $1,842 |
| Gabapentin | 16 | $767 |
| Cephalexin | 16 | $318 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $129 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Seattle
- David DalstromSeattle$491K
- Adam AlbabaSeattle$46K
- Stephen BenirschkeSeattle$45K
- Kivanc AtesokSeattle$16K
- Adam SangeorzanSeattle$12K
- Christopher PriceSeattle$11K
- Kenneth ChinSeattle$10K
- Anthony LoSeattle$6K
- Maduwilla SilvaSeattle$6K
- Salvatore RizzoSeattle$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.